Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha- and beta-blocking agents: pharmacology and properties.

B N Prichard1

  • 1Department of Clinical Pharmacology, University College and Middlesex School of Medicine, University College London, England.

Cleveland Clinic Journal of Medicine
|July 1, 1991
PubMed
Summary

New beta-blocking drugs offer improved treatment by not only blocking beta receptors but also providing a peripheral vasodilator effect. This dual action enhances their pharmacodynamic profile for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term treatment of hypertension with labetalol.

British journal of clinical pharmacology·2015
Same author

Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

British journal of clinical pharmacology·2015
Same author

Proceedings of the Second Symposium on Labetalol, London, March 1979.

British journal of clinical pharmacology·2015
Same author

An Examination of Some Factors which Influence the Stability of in Vitro Platelet Responses.

Platelets·2010
Same author

Collagen-induced Platelet Activation In Vitro Increases Plasma Catecholamine Concentration.

Platelets·2010
Same author

Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.

Proceedings of the Royal Society of Medicine·2010

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Adrenergic receptors are classified into alpha and beta types, with further subdivisions.
  • Pharmacological agents targeting these receptors exhibit varying specificity and pharmacodynamic profiles.

Purpose of the Study:

  • To highlight the development and characteristics of novel multiple-action beta-blocking drugs.
  • To explore the mechanisms behind the peripheral vasodilator effects of these advanced agents.

Main Methods:

  • Review of existing literature on adrenergic receptor pharmacology.
  • Analysis of pharmacodynamic data for novel beta-blocking agents with multiple actions.

Main Results:

  • Development of beta-blocking drugs with additional peripheral vasodilator properties.

Related Experiment Videos

  • Identification of potential mechanisms for vasodilation, including alpha blockade, beta-2 stimulation, or independent pathways.

    • Conclusions:

    • Multiple-action beta-blockers represent a significant advancement in cardiovascular pharmacotherapy.
    • Understanding the mechanisms of their vasodilatory effects is crucial for optimizing clinical application.